| Year |
Citation |
Score |
| 2013 |
Matushansky I, Dela Cruz F, Insel BJ, Hershman DL, Neugut AI. Chemotherapy use in elderly patients with soft tissue sarcoma: a population-based study. Cancer Investigation. 31: 83-91. PMID 23320812 DOI: 10.3109/07357907.2012.756112 |
0.325 |
|
| 2012 |
Zhang X, Cruz FD, Terry M, Remotti F, Matushansky I. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene. 32: 2249-60, 2260.e1-21. PMID 22777357 DOI: 10.1038/Onc.2012.237 |
0.514 |
|
| 2012 |
Cruz FD, Matushansky I. Solid tumor differentiation therapy - is it possible? Oncotarget. 3: 559-67. PMID 22643847 DOI: 10.18632/Oncotarget.512 |
0.48 |
|
| 2012 |
Siddiqi S, Terry M, Matushansky I. Hiwi mediated tumorigenesis is associated with DNA hypermethylation. Plos One. 7: e33711. PMID 22438986 DOI: 10.1371/Journal.Pone.0033711 |
0.621 |
|
| 2012 |
Dela Cruz F, Terry M, Matushansky I. A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects. Differentiation; Research in Biological Diversity. 83: 220-30. PMID 22406973 DOI: 10.1016/J.Diff.2012.01.001 |
0.301 |
|
| 2012 |
Charytonowicz E, Matushansky I, Doménech JD, Castillo-Martín M, Ladanyi M, Cordon-Cardo C, Ziman M. PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 14: 197-206. PMID 22374423 DOI: 10.1007/S12094-012-0784-4 |
0.372 |
|
| 2012 |
Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I. PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma. The Journal of Clinical Investigation. 122: 886-98. PMID 22293175 DOI: 10.1172/Jci60015 |
0.419 |
|
| 2012 |
Siddiqi S, Matushansky I. Piwis and piwi-interacting RNAs in the epigenetics of cancer. Journal of Cellular Biochemistry. 113: 373-80. PMID 21928326 DOI: 10.1002/Jcb.23363 |
0.606 |
|
| 2011 |
Siddiqi S, Terry M, Matushansky I. The role of HIWI in stem cell maintenance and sarcomagenesis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e20500. PMID 28020915 DOI: 10.1200/jco.2011.29.15_suppl.e20500 |
0.364 |
|
| 2011 |
Matushansky I, Taub RN. Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma. Nature Reviews. Clinical Oncology. 8: 434-8. PMID 21423256 DOI: 10.1038/Nrclinonc.2011.36 |
0.32 |
|
| 2011 |
Mills J, Hricik T, Siddiqi S, Matushansky I. Chromatin structure predicts epigenetic therapy responsiveness in sarcoma. Molecular Cancer Therapeutics. 10: 313-24. PMID 21216937 DOI: 10.1158/1535-7163.Mct-10-0724 |
0.588 |
|
| 2010 |
Siddiqi S, Mills J, Matushansky I. Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas. Current Stem Cell Research & Therapy. 5: 63-73. PMID 19807660 DOI: 10.2174/157488810790442859 |
0.639 |
|
| 2009 |
Mills J, Matos T, Charytonowicz E, Hricik T, Castillo-Martin M, Remotti F, Lee FY, Matushansky I. Characterization and comparison of the properties of sarcoma cell lines in vitro and in vivo. Human Cell. 22: 85-93. PMID 19874397 DOI: 10.1111/J.1749-0774.2009.00073.X |
0.388 |
|
| 2009 |
Matushansky I, Charytonowicz E, Mills J, Siddiqi S, Hricik T, Cordon-Cardo C. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century. Expert Review of Anticancer Therapy. 9: 1135-44. PMID 19671033 DOI: 10.1586/Era.09.76 |
0.565 |
|
| 2009 |
Charytonowicz E, Cordon-Cardo C, Matushansky I, Ziman M. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Letters. 279: 126-36. PMID 19008039 DOI: 10.1016/J.Canlet.2008.09.039 |
0.444 |
|
| 2008 |
Matushansky I, Hernando E, Socci ND, Matos T, Mills J, Edgar MA, Schwartz GK, Singer S, Cordon-Cardo C, Maki RG. A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. The American Journal of Pathology. 172: 1069-80. PMID 18310505 DOI: 10.2353/Ajpath.2008.070284 |
0.475 |
|
| 2008 |
Matushansky I, Maki RG, Cordon-Cardo C. A context dependent role for Wnt signaling in tumorigenesis and stem cells. Cell Cycle (Georgetown, Tex.). 7: 720-4. PMID 18239459 DOI: 10.4161/Cc.7.6.5569 |
0.408 |
|
| 2007 |
Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. The Journal of Clinical Investigation. 117: 3248-57. PMID 17948129 DOI: 10.1172/Jci31377 |
0.469 |
|
| 2007 |
Hernando E, Charytonowicz E, Dudas ME, Menendez S, Matushansky I, Mills J, Socci ND, Behrendt N, Ma L, Maki RG, Pandolfi PP, Cordon-Cardo C. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nature Medicine. 13: 748-53. PMID 17496901 DOI: 10.1038/Nm1560 |
0.323 |
|
| 2006 |
Matushansky I, Socci N, Hernando E, Singer S, Schwartz G, Cordon-Cardo C, Maki R. A putative tumor suppressor role for Wnt-signaling in sarcomagenesis Journal of Clinical Oncology. 24: 9507-9507. DOI: 10.1200/Jco.2006.24.18_Suppl.9507 |
0.435 |
|
| 2005 |
Matushansky I, Maki RG. Mechanisms of sarcomagenesis. Hematology/Oncology Clinics of North America. 19: 427-49, v. PMID 15939190 DOI: 10.1016/J.Hoc.2005.03.006 |
0.413 |
|
| 2003 |
Choe KS, Radparvar F, Matushansky I, Rekhtman N, Han X, Skoultchi AI. Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1. Cancer Research. 63: 6363-9. PMID 14559825 |
0.365 |
|
| 2003 |
Matushansky I, Radparvar F, Skoultchi AI. CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells. Oncogene. 22: 4143-9. PMID 12833137 DOI: 10.1038/Sj.Onc.1206484 |
0.343 |
|
| Show low-probability matches. |